Literature DB >> 3620981

Kinetic analysis of 'rapid onset' neurite formation in NG108-15 cells reveals a dual role for substratum-bound laminin.

N R Smalheiser, N B Schwartz.   

Abstract

Undifferentiated neural hybrid NG108-15 cells plated on laminin-coated, polylysine-treated plastic Petri dishes in minimal serum-free media formed long neurites within 1-4 h post-plating. Morphologic features and pharmacologic responses of these 'rapid onset' neurites were strikingly similar to those of neuronal growth cones. Cycloheximide (1-10 micrograms/ml) and forskolin (10(-7) to 10(-6) M) accelerated the initial formation of laminin-stimulated neurites, but did not cause rapid onset neurites to emerge upon Petri dishes coated with polylysine alone. Quantitative study of the substratum-dependent effect of cycloheximide showed that it was additive even with maximally effective amounts of laminin, independent of the magnitude of the laminin-stimulated baseline rate and not limited by an inherent ceiling in the rate at which neurites could form. The methylation inhibitor 5'-deoxy-5'-methyl thioadenosine (MTA) (3 X 10(-4) to 3 X 10(-3) M) did stimulate neurites to form on polylysine. MTA- and laminin-stimulated neurites were similar in their susceptibility to calmodulin antagonists and the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA). However, formation of MTA-stimulated neurites was not accelerated by cycloheximide. A simple two-compartment kinetic model of 'rapid onset' neurite formation is proposed: compartment A is common to both laminin- and MTA-stimulated neurites. Compartment B is affected by cycloheximide, and its access to the neurite formation machinery contained in compartment A is gated according to the nature of the substratum. In addition to its direct effects, laminin controls the relative dominance of the two kinetic compartments via modulating the effectiveness of other signals acting upon an endogenously active compartment B.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3620981     DOI: 10.1016/0165-3806(87)90200-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Effect of cytochalasin D on the adhesion of a neuroblastoma x glioma cell line (NG108-15) to laminin and plastic substrates.

Authors:  L Luckenbill-Edds
Journal:  Cell Tissue Res       Date:  1990-05       Impact factor: 5.249

2.  Cranin: a laminin-binding protein of cell membranes.

Authors:  N R Smalheiser; N B Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Lignosus rhinocerus (Cooke) Ryvarden: A Medicinal Mushroom That Stimulates Neurite Outgrowth in PC-12 Cells.

Authors:  Lee-Fang Eik; Murali Naidu; Pamela David; Kah-Hui Wong; Yee-Shin Tan; Vikineswary Sabaratnam
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-06       Impact factor: 2.629

4.  6-shogaol, a neuroactive compound of ginger (jahe gajah) induced neuritogenic activity via NGF responsive pathways in PC-12 cells.

Authors:  Syntyche Ling Sing Seow; Sok Lai Hong; Guan Serm Lee; Sri Nurestri Abd Malek; Vikineswary Sabaratnam
Journal:  BMC Complement Altern Med       Date:  2017-06-24       Impact factor: 3.659

5.  Optimisation of a PC12 cell-based in vitro stroke model for screening neuroprotective agents.

Authors:  PinFen Chua; William K Lim
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

6.  Uridine from Pleurotus giganteus and Its Neurite Outgrowth Stimulatory Effects with Underlying Mechanism.

Authors:  Chia-Wei Phan; Pamela David; Kah-Hui Wong; Murali Naidu; Vikineswary Sabaratnam
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

7.  Lignosus rhinocerotis (Cooke) Ryvarden mimics the neuritogenic activity of nerve growth factor via MEK/ERK1/2 signaling pathway in PC-12 cells.

Authors:  Syntyche Ling-Sing Seow; Lee-Fang Eik; Murali Naidu; Pamela David; Kah-Hui Wong; Vikineswary Sabaratnam
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.